In an amicus brief in support of petitioners written for AAI by Paul Slater (Sperling & Slater PC), we urge Supreme Court to grant certiorari and overturn Second Circuit opinion in Tamoxifen Citrate Antitrust Litigation, where issue is ability of name brand drug companies to use reverse payments to keep lower price generic drugs off the market.
Click here for the brief.
